10-K Filing

GLUCOSE HEALTH, INC. CIK: 1420108 FY 2012

Filing Information

Form Type	10-K
Accession Number	`0001477932-13-001273`
Period End Date	20121231
Filing Date	20130322
Fiscal Year	2012
Fiscal Period	FY
XBRL Instance	bisu-20121231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 52 Income Statement 57 Cash Flow Statement 59 Stockholders Equity 28

Balance Sheet 52 line items

Line Item	Tag	Value	Unit	Period
Cash	`Cash`	$82.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash	`Cash`	$1.08K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$27.00K	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	-	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	65.44M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$1.08K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$27.08K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	101.09M	shares	Point-in-time
Intellectual Property	`IndefiniteLivedIntangibleAssetsExcludingGoodwill`	$206.60K	USD	Point-in-time
Intellectual Property	`IndefiniteLivedIntangibleAssetsExcludingGoodwill`	$206.60K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	65.44M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	101.09M	shares	Point-in-time
TOTAL ASSETS	`Assets`	$207.68K	USD	Point-in-time
TOTAL ASSETS	`Assets`	$233.68K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$123.20K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$296.43K	USD	Point-in-time
Liability for stock to be issued	`LiabilityForStockToBeIssued`	-	USD	Point-in-time
Liability for stock to be issued	`LiabilityForStockToBeIssued`	$41.50K	USD	Point-in-time
Short - term loans	`NotesPayableCurrent`	-	USD	Point-in-time
Short - term loans	`NotesPayableCurrent`	$19.67K	USD	Point-in-time
Short - term loans - related parties	`DueToRelatedPartiesCurrent`	$1.60K	USD	Point-in-time
Short - term loans - related parties	`DueToRelatedPartiesCurrent`	$49.16K	USD	Point-in-time
Short - term loans - convertible	`ConvertibleNotesPayableCurrent`	$8.20K	USD	Point-in-time
Short - term loans - convertible	`ConvertibleNotesPayableCurrent`	$60.68K	USD	Point-in-time
Due to officer	`DueToOfficersOrStockholdersCurrent`	$4.75K	USD	Point-in-time
Due to officer	`DueToOfficersOrStockholdersCurrent`	-	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$419.70K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$185.48K	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$185.48K	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$419.70K	USD	Point-in-time
Common stock, $0.001 par value, 200,000,000 shares authorized 101,085,862 and 65,440,397 shares issued and outstanding as of December 31, 2012 and 2011, respectively	`CommonStockValue`	$65.44K	USD	Point-in-time
Common stock, $0.001 par value, 200,000,000 shares authorized 101,085,862 and 65,440,397 shares issued and outstanding as of December 31, 2012 and 2011, respectively	`CommonStockValue`	$101.09K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalCommonStock`	$2.86M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalCommonStock`	$3.59M	USD	Point-in-time
Deferred Compensation	`DeferredCompensationLiabilityCurrent`	$-150.00K	USD	Point-in-time
Deferred Compensation	`DeferredCompensationLiabilityCurrent`	-	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-2.87M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-2.87M	USD	Point-in-time
Deficit accumulated during the development stage	`DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage`	$568.65K	USD	Point-in-time
Deficit accumulated during the development stage	`DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage`	$169.57K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-75.28K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-69.22K	USD	Point-in-time
Total stockholders equity (deficiency)	`StockholdersEquity`	$22.20K	USD	Point-in-time
Total stockholders equity (deficiency)	`StockholdersEquity`	$-186.02K	USD	Point-in-time
Total stockholders equity (deficiency)	`StockholdersEquity`	$-310.14K	USD	Point-in-time
Total stockholders equity (deficiency)	`StockholdersEquity`	$-594.57K	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS EQUITY (DEFICIENCY)	`LiabilitiesAndStockholdersEquity`	$233.68K	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS EQUITY (DEFICIENCY)	`LiabilitiesAndStockholdersEquity`	$207.68K	USD	Point-in-time

Income Statement 57 line items

Line Item	Tag	Value	Unit	Period
REVENUE	`SalesRevenueGoodsNet`	-	USD	Annual
REVENUE	`SalesRevenueGoodsNet`	-	USD	5 Qtrs
REVENUE	`SalesRevenueGoodsNet`	-	USD	Annual
Beginning inventory	`InventoryFinishedGoods`	$87.76K	USD	Point-in-time
Beginning inventory	`InventoryFinishedGoods`	-	USD	Point-in-time
Beginning inventory	`InventoryFinishedGoods`	-	USD	Point-in-time
Beginning inventory	`InventoryFinishedGoods`	-	USD	Point-in-time
Purchases/Write-off of obsolete inventory	`PurchasesWriteoffOfObsoleteInventory`	$3.63K	USD	5 Qtrs
Purchases/Write-off of obsolete inventory	`PurchasesWriteoffOfObsoleteInventory`	-	USD	Annual
Purchases/Write-off of obsolete inventory	`PurchasesWriteoffOfObsoleteInventory`	$-87.76K	USD	Annual
Ending inventory	`InventoryFinishedGoods`	$87.76K	USD	Point-in-time
Ending inventory	`InventoryFinishedGoods`	-	USD	Point-in-time
Ending inventory	`InventoryFinishedGoods`	-	USD	Point-in-time
Ending inventory	`InventoryFinishedGoods`	-	USD	Point-in-time
Total Cost of Revenues	`CostOfGoodsSold`	$3.63K	USD	5 Qtrs
Total Cost of Revenues	`CostOfGoodsSold`	-	USD	Annual
Total Cost of Revenues	`CostOfGoodsSold`	-	USD	Annual
GROSS PROFIT (LOSS)	`GrossProfit`	-	USD	Annual
GROSS PROFIT (LOSS)	`GrossProfit`	-	USD	Annual
GROSS PROFIT (LOSS)	`GrossProfit`	$-3.63K	USD	5 Qtrs
Professional fees	`SalariesAndWages`	$788.86K	USD	Annual
Professional fees	`SalariesAndWages`	$355.66K	USD	Annual
Professional fees	`SalariesAndWages`	$437.28K	USD	5 Qtrs
Amortization expense and impairment	`AmortizationExpenseAndImpairment`	$85.29K	USD	5 Qtrs
Amortization expense and impairment	`AmortizationExpenseAndImpairment`	-	USD	Annual
Amortization expense and impairment	`AmortizationExpenseAndImpairment`	$85.29K	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$14.67K	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$5.77K	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$6.28K	USD	5 Qtrs
Total Operating Expenses	`OperatingExpenses`	$528.85K	USD	5 Qtrs
Total Operating Expenses	`OperatingExpenses`	$361.42K	USD	Annual
Total Operating Expenses	`OperatingExpenses`	$888.81K	USD	Annual
NET LOSS BEFORE OTHER EXPENSE	`OperatingIncomeLoss`	$-532.48K	USD	5 Qtrs
NET LOSS BEFORE OTHER EXPENSE	`OperatingIncomeLoss`	$-888.81K	USD	Annual
NET LOSS BEFORE OTHER EXPENSE	`OperatingIncomeLoss`	$-361.42K	USD	Annual
Interest expense	`InterestExpense`	$37.66K	USD	Annual
Interest expense	`InterestExpense`	$36.17K	USD	5 Qtrs
Interest expense	`InterestExpense`	$10.37K	USD	Annual
Total other expense	`NonoperatingIncomeExpense`	$-10.37K	USD	Annual
Total other expense	`NonoperatingIncomeExpense`	$-37.66K	USD	Annual
Total other expense	`NonoperatingIncomeExpense`	$-36.17K	USD	5 Qtrs
NET LOSS	`NetIncomeLoss`	$-568.65K	USD	5 Qtrs
NET LOSS	`NetIncomeLoss`	$-399.08K	USD	Annual
NET LOSS	`NetIncomeLoss`	$-899.19K	USD	Annual
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING	`WeightedAverageNumberOfSharesOutstandingBasic`	36.26M	shares	Annual
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING	`WeightedAverageNumberOfSharesOutstandingBasic`	76.05M	shares	Annual
NET LOSS PER SHARE	`EarningsPerShareBasic`	$-0.01	USD	Annual
NET LOSS PER SHARE	`EarningsPerShareBasic`	$-0.02	USD	Annual
Net loss	`NetIncomeLoss`	$-568.65K	USD	5 Qtrs
Net loss	`NetIncomeLoss`	$-399.08K	USD	Annual
Net loss	`NetIncomeLoss`	$-899.19K	USD	Annual
Currency translation gains (losses)	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-6.06K	USD	Annual
Currency translation gains (losses)	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-1.20K	USD	Annual
Currency translation gains (losses)	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-12.58K	USD	5 Qtrs
TOTAL ACCUMULATED OTHER COMPREHENSIVE LOSS	`ComprehensiveIncomeNetOfTax`	$-405.14K	USD	Annual
TOTAL ACCUMULATED OTHER COMPREHENSIVE LOSS	`ComprehensiveIncomeNetOfTax`	$-581.23K	USD	5 Qtrs
TOTAL ACCUMULATED OTHER COMPREHENSIVE LOSS	`ComprehensiveIncomeNetOfTax`	$-900.38K	USD	Annual

Cash Flow Statement 59 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-568.65K	USD	5 Qtrs
Net loss	`NetIncomeLoss`	$-399.08K	USD	Annual
Net loss	`NetIncomeLoss`	$-899.19K	USD	Annual
Impairment expense	`AssetImpairmentCharges`	$85.29K	USD	Annual
Impairment expense	`AssetImpairmentCharges`	$85.29K	USD	5 Qtrs
Impairment expense	`AssetImpairmentCharges`	-	USD	Annual
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$259.18K	USD	Annual
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$352.37K	USD	5 Qtrs
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$701.01K	USD	Annual
Beneficial Conversion Feature of Notes Payable	`DebtInstrumentConvertibleBeneficialConversionFeature`	$-34.30K	USD	5 Qtrs
Beneficial Conversion Feature of Notes Payable	`DebtInstrumentConvertibleBeneficialConversionFeature`	$-34.30K	USD	Annual
Beneficial Conversion Feature of Notes Payable	`DebtInstrumentConvertibleBeneficialConversionFeature`	-	USD	Annual
Increase (decrease) in accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$21.92K	USD	Annual
Increase (decrease) in accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$8.01K	USD	5 Qtrs
Increase (decrease) in accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$89.58K	USD	Annual
Total adjustments	`AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$315.39K	USD	Annual
Total adjustments	`AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$875.88K	USD	Annual
Total adjustments	`AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$479.96K	USD	5 Qtrs
Net cash (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-23.30K	USD	Annual
Net cash (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-83.69K	USD	Annual
Net cash (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-88.69K	USD	5 Qtrs
Issuance of stock for cash	`ProceedsFromIssuanceOfCommonStock`	-	USD	5 Qtrs
Issuance of stock for cash	`ProceedsFromIssuanceOfCommonStock`	$11.48K	USD	Annual
Issuance of stock for cash	`ProceedsFromIssuanceOfCommonStock`	-	USD	Annual
Proceeds from short-term loans, net of repayments	`ProceedsFromRepaymentsOfShortTermDebt`	$-1.39K	USD	5 Qtrs
Proceeds from short-term loans, net of repayments	`ProceedsFromRepaymentsOfShortTermDebt`	$-1.39K	USD	Annual
Proceeds from short-term loans, net of repayments	`ProceedsFromRepaymentsOfShortTermDebt`	-	USD	Annual
Proceeds from short-term loans - related party, net of repayments	`ShorttermLoansRelatedPartyNetOfRepayments`	$4.87K	USD	5 Qtrs
Proceeds from short-term loans - related party, net of repayments	`ShorttermLoansRelatedPartyNetOfRepayments`	-	USD	Annual
Proceeds from short-term loans - related party, net of repayments	`ShorttermLoansRelatedPartyNetOfRepayments`	$2.48K	USD	Annual
Proceeds from convertible notes payable, net of repayments	`ProceedsFromRepaymentsOfOtherDebt`	$78.60K	USD	Annual
Proceeds from convertible notes payable, net of repayments	`ProceedsFromRepaymentsOfOtherDebt`	$8.20K	USD	Annual
Proceeds from convertible notes payable, net of repayments	`ProceedsFromRepaymentsOfOtherDebt`	$76.85K	USD	5 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$78.60K	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$80.33K	USD	5 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$20.77K	USD	Annual
Effect of foreign currency	`EffectOfExchangeRateOnCashAndCashEquivalents`	$5.51K	USD	5 Qtrs
Effect of foreign currency	`EffectOfExchangeRateOnCashAndCashEquivalents`	$6.08K	USD	Annual
Effect of foreign currency	`EffectOfExchangeRateOnCashAndCashEquivalents`	$2.58K	USD	Annual
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$994.00	USD	Annual
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$49.00	USD	Annual
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-2.85K	USD	5 Qtrs
CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$33.00	USD	Point-in-time
CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$82.00	USD	Point-in-time
CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$3.93K	USD	Point-in-time
CASH AND CASH EQUIVALENTS - END OF PERIOD	`CashEquivalentsAtCarryingValue`	$82.00	USD	Point-in-time
CASH AND CASH EQUIVALENTS - END OF PERIOD	`CashEquivalentsAtCarryingValue`	$1.08K	USD	Point-in-time
Conversion of notes payable and accrued interest to common stock	`DebtConversionConvertedInstrumentAmount1`	$64.14K	USD	5 Qtrs
Conversion of notes payable and accrued interest to common stock	`DebtConversionConvertedInstrumentAmount1`	$246.61K	USD	Annual
Conversion of notes payable and accrued interest to common stock	`DebtConversionConvertedInstrumentAmount1`	$54.28K	USD	Annual
Conversion of liability to common stock	`StockIssued1`	$47.80K	USD	5 Qtrs
Conversion of liability to common stock	`StockIssued1`	$152.68K	USD	Annual
Conversion of liability to common stock	`StockIssued1`	$47.80K	USD	Annual
Acquisition of intellectual property of Type2 Defense for common shares	`StockIssued2`	$6.60K	USD	5 Qtrs
Acquisition of intellectual property of Type2 Defense for common shares	`StockIssued2`	$206.60K	USD	Annual
Acquisition of intellectual property of Type2 Defense for common shares	`StockIssued2`	-	USD	Annual
Conversion of accounts payable and notes payable to equity (Note 7)	`OtherSignificantNoncashTransactionValueOfConsiderationGiven1`	$73.75K	USD	Annual
Conversion of accounts payable and notes payable to equity (Note 7)	`OtherSignificantNoncashTransactionValueOfConsiderationGiven1`	$291.56K	USD	5 Qtrs
Conversion of accounts payable and notes payable to equity (Note 7)	`OtherSignificantNoncashTransactionValueOfConsiderationGiven1`	$217.81K	USD	Annual

Stockholders Equity 28 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance, Amount	`StockholdersEquity`	$22.20K	USD	Point-in-time
Beginning Balance, Amount	`StockholdersEquity`	$-186.02K	USD	Point-in-time
Beginning Balance, Amount	`StockholdersEquity`	$-310.14K	USD	Point-in-time
Beginning Balance, Amount	`StockholdersEquity`	$-594.57K	USD	Point-in-time
Common shares issued for services, Amount	`StockIssuedDuringPeriodValueIssuedForServices`	$607.82K	USD	3 Qtrs
Common shares issued for services, Amount	`StockIssuedDuringPeriodValueIssuedForServices`	$10.00K	USD	1 Quarter
Common shares issued for services, Amount	`StockIssuedDuringPeriodValueIssuedForServices`	$184.18K	USD	Annual
Common shares issued for settlement of accounts payable, Amount	`CommonSharesIssuedForSettlementOfAccountsPayableAmount`	$152.68K	USD	3 Qtrs
Common shares issued for settlement of accounts payable, Amount	`CommonSharesIssuedForSettlementOfAccountsPayableAmount`	$6.30K	USD	Annual
Common shares issued for settlement of notes payable, Amount	`CommonSharesIssuedForSettlementOfNotesPayableAmount`	$9.86K	USD	1 Quarter
Common shares issued for settlement of notes payable, Amount	`CommonSharesIssuedForSettlementOfNotesPayableAmount`	$236.75K	USD	3 Qtrs
Common shares issued for settlement of notes payable, Amount	`CommonSharesIssuedForSettlementOfNotesPayableAmount`	$54.28K	USD	Annual
Proceeds from issuance of common stock, Amount	`ProceedsFromIssuanceOfCommonStockAmount`	$11.48K	USD	3 Qtrs
Common shares issued for Type 2 Acquisition, Amount	`CommonSharesIssuedForType2AcquisitionAmount`	$206.60K	USD	1 Quarter
Common shares issued for Type 2 Acquisition, Amount	`CommonSharesIssuedForType2AcquisitionAmount`	$206.60K	USD	Annual
Conversion of accounts payable to equity (Note 7)	`ConversionOfAccountsPayableToEquityNote7`	$73.75K	USD	1 Quarter
Common shares issued for liability for stock to be issued, Amount	`CommonSharesIssuedForLiabilityForStockToBeIssuedAmount`	$41.50K	USD	Annual
Common shares issued for compensation under employment agreement, Amount	`CommonSharesIssuedForCompensationUnderEmploymentAgreementAmount`	-	USD	Annual
Conversion of accounts payable and notes payable to equity (Note 7)	`ConversionOfAccountsPayableAndNotesPayableToEquityNote7`	$217.81K	USD	Annual
Beneficial Conversion Feature of Notes Payable	`BeneficialConversionFeatureOfNotesPayable`	$34.30K	USD	Annual
Amortization of deferred compensation	`AmortizationOfDeferredCompensation`	$75.00K	USD	Annual
Net loss	`ProfitLoss`	$-405.14K	USD	Annual
Net loss	`ProfitLoss`	$-724.29K	USD	3 Qtrs
Net loss	`ProfitLoss`	$-176.09K	USD	1 Quarter
Ending Balance, Amount	`StockholdersEquity`	$22.20K	USD	Point-in-time
Ending Balance, Amount	`StockholdersEquity`	$-186.02K	USD	Point-in-time
Ending Balance, Amount	`StockholdersEquity`	$-310.14K	USD	Point-in-time
Ending Balance, Amount	`StockholdersEquity`	$-594.57K	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.